OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

AstraZeneca PLC/  GB0009895292  /

Cboe Europe BXE
2024-04-17  5:35:30 PM Chg. +13.00 Volume Bid5:35:30 PM Ask5:35:30 PM Market Capitalization Dividend Y. P/E Ratio
10,903.00GBX +0.12% 218,145
Turnover(GBP): 23.7 mill.		 -Bid Size: - -Ask Size: - 167.69 bill.GBP - -
GlobeNewswire 04-01 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 03-28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire 03-19 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 03-19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 03-18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 03-14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 03-14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 02-26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 02-22 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 02-22 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 02-20 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 02-19 Europe closes mostly flat with eyes on earnings, data
TeleTrader 02-12 US opens mostly lower with CPI in focus
TeleTrader 02-08 Europe closes mostly higher following earnings
TeleTrader 02-08 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 02-08 AstraZeneca's revenue in Q4 rises 5% to $11.3B
GlobeNewswire 02-05 Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire 02-02 BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire 01-16 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire 01-10 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
GlobeNewswire 01-08 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Bioph...
GlobeNewswire 01-04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, I...
GlobeNewswire 01-04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, I...